Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 626–650 của 4,086 tạp chí khoa học quốc tế (Medicine)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #626 | Clinical Autonomic Research ISSN: 0959-9851 / 1619-1560 | 4.6 | 77 | Q1 | 1.067Q1 | CAS Tier 3 | 7.7% | 37 | Springer Berlin Heidelberg |
| #627 | Cns Spectrums ISSN: 1092-8529 / 2165-6509 | 4.6 | 100 | Q1 | 1.086Q1 | CAS Tier 2 | 0% | 126 | Cambridge University Press |
| #628 | Dermatology and Therapy ISSN: 2193-8210 / 2190-9172 | 4.6 | 62 | Q1 | 1.595Q1 | CAS Tier 2 | 8.6% | 171 | Springer Healthcare |
| #629 | Endocrine Pathology ISSN: 1046-3976 / 1559-0097Top Tier | 4.6 | 65 | Q2 | 3.715Q1 | CAS Tier 2 | 12.4% | 42 | Springer US |
| #630 | Endocrinology and Metabolism Clinics of North America ISSN: 0889-8529 / 1558-4410Top Tier | 4.6 | 130 | Q2 | 1.489Q1 | CAS Tier 3 | 0% | 52 | W.B. Saunders Ltd |
| #631 | Environmental Toxicology and Pharmacology ISSN: 1382-6689 / 1872-7077 | 4.6 | 117 | Q2 | 1.161Q1 | CAS Tier 3 | 7.1% | 170 | Elsevier |
| #632 | Exercise Immunology Review ISSN: 1077-5552Top Tier | 4.6 | 65 | Q2 | 1.22Q1 | CAS Tier 4 | 5.7% | — | Human Kinetics Publishers Inc. |
| #633 | Expert Review of Anti-Infective Therapy ISSN: 1478-7210 / 1744-8336Top Tier | 4.6 | 110 | Q1 | 1.024Q1 | CAS Tier 3 | 2.4% | 116 | Taylor and Francis Ltd. |
| #634 | Helicobacter ISSN: 1083-4389 / 1523-5378 | 4.6 | 99 | Q1 | 1.079Q1 | CAS Tier 2 | 11.6% | 75 | Wiley-Blackwell Publishing Ltd |
| #635 | Human Gene Therapy ISSN: 1043-0342 / 1557-7422 | 4.6 | 167 | Q2 | 1.282Q1 | CAS Tier 3 | 7.7% | 104 | Mary Ann Liebert Inc. |
| #636 | International Journal of Infectious Diseases ISSN: 1201-9712 / 1878-3511Top Tier | 4.6 | 146 | Q1 | 1.344Q1 | CAS Tier 2 | 2.1% | 944 | Elsevier |
| #637 | Journal of Dermatological Science ISSN: 0923-1811 / 1873-569X | 4.6 | 120 | Q1 | 1.1Q1 | CAS Tier 3 | 0% | 77 | Elsevier Ireland Ltd |
| #638 | Journal of Esthetic and Restorative Dentistry ISSN: 1496-4155 / 1708-8240 | 4.6 | 86 | Q1 | 1.452Q1 | CAS Tier 2 | 12.5% | 111 | Wiley-Blackwell |
| #639 | Journal of Innate Immunity ISSN: 1662-811X / 1662-8128 | 4.6 | 91 | Q2 | 1.408Q1 | CAS Tier 3 | 2.1% | 49 | S. Karger AG |
| #640 | Journal of Neurochemistry ISSN: 0022-3042 / 1471-4159 | 4.6 | 273 | Q2 | 1.472Q1 | CAS Tier 3 | 2.4% | 222 | Wiley-Blackwell Publishing Ltd |
| #641 | Journal of Physiology-London ISSN: 0022-3751 / 1469-7793 | 4.6 | 285 | Q1 | 1.476Q1 | CAS Tier 2 | 6.4% | 258 | Wiley-Blackwell Publishing Ltd |
| #642 | Journal of Sleep Research ISSN: 0962-1105 / 1365-2869 | 4.6 | 152 | Q1 | 1.534Q1 | CAS Tier 3 | 8.8% | 223 | Wiley-Blackwell Publishing Ltd |
| #643 | Journal of the American Geriatrics Society ISSN: 0002-8614Top Tier | 4.6 | 282 | Q2 | 1.711Q1 | CAS Tier 2 | 9.3% | 343 | Wiley-Blackwell Publishing Ltd |
| #644 | Journals of Gerontology Series A-Biological Sciences and Medical Sciences ISSN: 1079-5006Top Tier | 4.6 | 238 | Q2 | 1.376Q1 | CAS Tier 2 | 4.7% | 398 | Oxford University Press |
| #645 | Nanomedicine ISSN: 1743-5889 / 1748-6963 | 4.6 | 148 | Q2 | 0.681Q1 | CAS Tier 3 | 4.3% | 149 | Future Medicine Ltd. |
| #646 | Oncology Research ISSN: 0965-0407 / 1555-3906 | 4.6 | 79 | Q2 | 1.102Q1 | CAS Tier 2 | 0% | 27 | Cognizant Communication Corporation |
| #647 | Progress in Neurobiology ISSN: 0301-0082 / 1873-5118Top Tier | 4.6 | 272 | Q1 | 2.405Q1 | CAS Tier 2 | 0% | 137 | Elsevier Ltd |
| #648 | Balkan Medical Journal ISSN: 2146-3123 / 2146-3131Diamond OA | 4.5 | 35 | Q1 | 0.746Q2 Diamond OA | CAS Tier 3 | 10.5% | 43 | Galenos Yayinevi |
| #649 | Biologics-Targets & Therapy ISSN: 1177-5475 / 1177-5491 | 4.5 | 53 | Q2 | 0.989Q1 | CAS Tier 3 | 0% | 40 | Dove Medical Press |
| #650 | Brain Research Bulletin ISSN: 0361-9230 / 1873-2747 | 4.5 | 154 | Q2 | 1.245Q1 | CAS Tier 3 | 2.9% | 290 | Elsevier Inc. |